Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Avage
Active Ingredient: Tazarotene 1mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Sales LLC, Waco, Texas, United States of America
Product: Ferodan
Active Ingredient: Ferrous sulphate 30mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Entreprises Importfab Inc, Point Claire, Quebec, Canada
Product: Lemsip Max Cold & Flu Lemon
Active Ingredients: Paracetamol 1,000mgPhenylephrine hydrochloride 12.2mg equivalent to 10mg phenylephrine
Dosage Form: Powder for oral solution
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare (UK) Limited, Hull, North Humberside, United Kingdom
Product: Sudafed PE Phenylephrine Nasal Decongestant
Active Ingredient: Phenylephrine hydrochloride 10mg
Dosage Form: Tablet
New Zealand Sponsor: Pfizer New Zealand Ltd
Manufacturer: Pfizer Australia Pty Limited, West Ryde, New South Wales, Australia
Product: Zorac
Active Ingredient: Tazarotene 0.5mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Sales LLC, Waco, Texas, United States of America
Product: Zorac
Active Ingredient: Tazarotene 1mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Sales LLC, Waco, Texas, United States of America
Dated this 24th day of March 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).